Back
Supernus Pharmaceuticals Stock Price Chart
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
43
SUPN
Supernus Pharmaceuticals
Last Price:
37.75
Seasonality Move:
8.24%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SUPN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Supernus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.37 | Buy |
| 20-day SMA: | 33.74 | Buy |
| 50-day SMA: | 33.03 | Buy |
| 200-day SMA: | 30.56 | Buy |
| 8-day EMA: | 34.35 | Buy |
| 20-day EMA: | 33.78 | Buy |
| 50-day EMA: | 32.92 | Buy |
| 200-day EMA: | 31.07 | Buy |
Supernus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.58 | Buy |
| Relative Strength Index (14 RSI): | 62.25 | Buy |
| Chaikin Money Flow: | -524292 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Supernus Pharmaceuticals Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Supernus Pharmaceuticals Stock
Is Supernus Pharmaceuticals Stock a Buy?
- Supernus Pharmaceuticals share price is 34.74 while SUPN 8-day simple moving average is 34.37, which is a Buy signal.
- The stock price of SUPN is 34.74 while Supernus Pharmaceuticals 20-day SMA is 33.74, which makes it a Buy.
- Supernus Pharmaceuticals 50-day simple moving average is 33.03 while SUPN share price is 34.74, making it a Buy technically.
- SUPN stock price is 34.74 and Supernus Pharmaceuticals 200-day simple moving average is 30.56, creating a Buy signal.
SUPN Technical Analysis vs Fundamental Analysis
Sell
43
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy or a Sell?
-
Supernus Pharmaceuticals stock is rated a Sell
The current Supernus Pharmaceuticals [SUPN] share price is $34.74. The Score for SUPN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Supernus Pharmaceuticals Stock Info
Market Cap:
1.92B
Price in USD:
34.74
Share Volume:
938.04K
Supernus Pharmaceuticals 52-Week Range
52-Week High:
39.37
52-Week Low:
23.05
Sell
43
Supernus Pharmaceuticals (SUPN)
is a Sell
Supernus Pharmaceuticals Share Price Forecast
-
What is the Supernus Pharmaceuticals stock price today?
The Supernus Pharmaceuticals stock price is 34.74 USD today. -
Will SUPN stock go up or go down?
Supernus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Supernus Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Supernus Pharmaceuticals is overvalued.
Is Supernus Pharmaceuticals Stock a Buy?
- Supernus Pharmaceuticals share price is 34.74 while SUPN 8-day exponential moving average is 34.35, which is a Buy signal.
- The stock price of SUPN is 34.74 while Supernus Pharmaceuticals 20-day EMA is 33.78, which makes it a Buy.
- Supernus Pharmaceuticals 50-day exponential moving average is 32.92 while SUPN share price is 34.74, making it a Buy technically.
- SUPN stock price is 34.74 and Supernus Pharmaceuticals 200-day simple moving average is 31.07, creating a Buy signal.
Fundamental Analysis of Supernus Pharmaceuticals
Is Supernus Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.87 per share, and a decrease next year of $0.96 per share.
Technical Analysis of Supernus Pharmaceuticals
Should I short Supernus Pharmaceuticals stock?
- SUPN Moving Average Covergence Divergence (MACD) indicator is 0.58, suggesting Supernus Pharmaceuticals is a Buy
- Supernus Pharmaceuticals Relative Strength Index (RSI) is 62.25, which suggest Supernus Pharmaceuticals is overbought
- The Bollinger Bands (25) for Supernus Pharmaceuticals is ( - ), which suggest Supernus Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Supernus Pharmaceuticals is ( - ), which suggest Supernus Pharmaceuticals is a Buy
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.